Observational study / 2007
Higher body mass index was linked to increased incidence of all cancers combined and 10 of 17 specific cancer types in UK women.
A prospective cohort of 1.2 million UK women aged 50-64 was followed for an average of 5.4 years for cancer incidence and 7.0 years for cancer mortality. Over follow-up, 45,037 incident cancers and 17,203 cancer deaths occurred. Per 10-unit increase in BMI, higher risk was observed for all cancers combined (RR 1.12, 95% CI 1.09 to 1.14), endometrial cancer (RR 2.89), oesophageal adenocarcinoma (RR 2.38), kidney cancer (RR 1.53), leukaemia (RR 1.50), postmenopausal breast cancer (RR 1.40), multiple myeloma (RR 1.31), pancreatic cancer (RR 1.24), non-Hodgkin's lymphoma (RR 1.17), ovarian cancer (RR 1.14), and premenopausal colorectal cancer (RR 1.61). The relationship between BMI and mortality was generally similar to incidence.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 1.2 million UK women aged 50-64 recruited into the Million Women Study
- What was measured
- Relative risks of cancer incidence and mortality for all cancers and 17 specific types
THE PAPER
Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study.
Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D, Million Women Study Collaboration. BMJ, 2007.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.